Frontlight ResearchEarly access
Trial site
NHO Osaka Toneyama Medical Center
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Duchenne muscular dystrophy3 trials
- Phase
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- NS Pharma, Inc.3 trials
Running trials
Enrolling by invitation
A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular Dystrophy
Active, not recruiting
Active, not recruiting
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Duchenne muscular dystrophy1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026